X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
index medicus (28) 28
hematology (26) 26
male (23) 23
middle aged (20) 20
female (17) 17
aged (15) 15
adult (14) 14
oncology (10) 10
cancer (9) 9
leukemia (9) 9
transplantation (9) 9
abridged index medicus (8) 8
retrospective studies (8) 8
immunology (7) 7
life sciences (7) 7
analysis (6) 6
care and treatment (6) 6
mutation (6) 6
chronic lymphatic leukemia (5) 5
chronic lymphocytic leukemia (5) 5
expression (5) 5
genetic aspects (5) 5
human health and pathology (5) 5
leukemia, lymphocytic, chronic, b-cell - genetics (5) 5
lymphomas (5) 5
prognosis (5) 5
research (5) 5
risk factors (5) 5
rituximab (5) 5
stem cells (5) 5
treatment outcome (5) 5
bone marrow (4) 4
chronic lymphocytic-leukemia (4) 4
diagnosis (4) 4
drug therapy (4) 4
health aspects (4) 4
hematopoietic stem cell transplantation - methods (4) 4
leukemia, lymphocytic, chronic, b-cell - drug therapy (4) 4
lymphatic leukemia (4) 4
multiple myeloma (4) 4
survival (4) 4
young adult (4) 4
adolescent (3) 3
aged, 80 and over (3) 3
animals (3) 3
chromosome aberrations (3) 3
clinical medicine (3) 3
clinical neurology (3) 3
cll (3) 3
complications and side effects (3) 3
disease-free survival (3) 3
erdheim-chester disease (3) 3
gene expression (3) 3
infection (3) 3
infectious diseases (3) 3
killer cells, natural - immunology (3) 3
klinisk medicin (3) 3
lymphoma (3) 3
medical and health sciences (3) 3
medical prognosis (3) 3
medical research (3) 3
medicin och hälsovetenskap (3) 3
medicine, experimental (3) 3
mice (3) 3
multiple myeloma - therapy (3) 3
mutations (3) 3
myelodysplastic syndrome (3) 3
nk cells (3) 3
online only (3) 3
online only articles (3) 3
p53 protein (3) 3
patients (3) 3
psychiatry (3) 3
surgery (3) 3
trial (3) 3
usage (3) 3
acute myeloid-leukemia (2) 2
adults (2) 2
alemtuzumab (2) 2
antibodies - blood (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
association (2) 2
bendamustine (2) 2
biochemistry, molecular biology (2) 2
blood (2) 2
bone marrow transplantation - methods (2) 2
bortezomib (2) 2
caliciviridae infections - diagnosis (2) 2
caliciviridae infections - virology (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
case studies (2) 2
cells (2) 2
chromosome 2 (2) 2
chromosomes, human, pair 12 - genetics (2) 2
chromosomes, human, pair 14 - genetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 2016, Volume 128, Issue 23, pp. 2666 - 2670
Journal Article
Leukemia, ISSN 0887-6924, 07/2017, Volume 31, Issue 7, pp. 1547 - 1554
Journal Article
BLOOD, ISSN 0006-4971, 08/2019, Volume 134, Issue 7, pp. 641 - 644
Mutational analyses performed following acquired ibrutinib resistance have suggested that chronic lymphocytic leukemia (CLL) progression on ibrutinib is linked... 
RESISTANCE | CHRONIC LYMPHOCYTIC-LEUKEMIA | MULTICENTER | AGENTS | HEMATOLOGY | INITIAL THERAPY | Life Sciences | Hematology | Human health and pathology
Journal Article
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 3, pp. 440 - 446
Journal Article
Transplantation, ISSN 0041-1337, 07/2011, Volume 92, Issue 1, pp. 61 - 69
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 03/2019, Volume 60, Issue 4, pp. 1092 - 1094
Journal Article
European Journal of Hospital Pharmacy, ISSN 2047-9956, 03/2018, Volume 25, Issue Suppl 1, p. A105
BackgroundChronic lymphocytic leukaemia and mantle cell lymphoma have a new standard of care: ibrutinib (metabolised by CYP3A4/5 and P-glycoprotein inhibitor).... 
Hypertension
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 2, pp. 240 - 247
Journal Article